Clinical Trial Update: A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 study comparing letrozole versus tamoxifen in postmenopausal women with hormone-sensitive resected primary breast cancer; the trial status is completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)
• Nolvadex (tamoxifen)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hormone Sensitive Resected Primary Breast Cancer in Postmenopausal Women | Phase 3 | Status: COMPLETED | Results posted: 2012-06-04